<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04622982</url>
  </required_header>
  <id_info>
    <org_study_id>1206/151217</org_study_id>
    <nct_id>NCT04622982</nct_id>
  </id_info>
  <brief_title>A Multidisciplinary Intervention for Weight Loss</brief_title>
  <official_title>Efficacy and Safety of a Long-term Multidisciplinary Weight Loss Intervention in Patients With Obesity: an Open Label Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda di Servizi alla Persona di Pavia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Azienda di Servizi alla Persona di Pavia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an open label study in which obese participants were treated with a restrictive&#xD;
      hypo-caloric diet under hospitalization for a maximum period of 3 months in a metabolic&#xD;
      rehabilitation unit. A multidisciplinary approach was used (combination of diet, physical&#xD;
      exercise and psychotherapy)&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 1, 2016</start_date>
  <completion_date type="Actual">September 30, 2020</completion_date>
  <primary_completion_date type="Actual">October 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Open Label study</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Body Weight</measure>
    <time_frame>12 weeks</time_frame>
    <description>Change in body Weight</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>GlycaemIa</measure>
    <time_frame>12 weeks</time_frame>
    <description>Change in glycaemia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insulin</measure>
    <time_frame>12 weeks</time_frame>
    <description>Change in insulin blood levels</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Homa IR</measure>
    <time_frame>12 weeks</time_frame>
    <description>Change in HOMA-IR</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total cholesterol</measure>
    <time_frame>12 weeks</time_frame>
    <description>Change in blood total cholesterol</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LDL cholesterol</measure>
    <time_frame>12 weeks</time_frame>
    <description>Change in LDL cholesterol</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HDL cholesterol</measure>
    <time_frame>12 weeks</time_frame>
    <description>Change in HDL cholesterol</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Triglycerides</measure>
    <time_frame>12 weeks</time_frame>
    <description>Change in triglycerides</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AST (Aspartate Aminotransferase)</measure>
    <time_frame>12 weeks</time_frame>
    <description>Change in blood of Aspartate Aminotransferase (AST)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ALT (alanine aminotransferase)</measure>
    <time_frame>12 weeks</time_frame>
    <description>Change in blood of alanine aminotransferase (ALT)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>GGT (gamma-glutamyl transpeptidase)</measure>
    <time_frame>12 weeks</time_frame>
    <description>Change in blood of gamma-glutamyl transpeptidase (GGT)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total bilirubin</measure>
    <time_frame>12 weeks</time_frame>
    <description>Change in blood total bilirubin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Basal metabolic rate</measure>
    <time_frame>12 weeks</time_frame>
    <description>Change in basal metabolic rate</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Body composition - Body Fat Mass</measure>
    <time_frame>12 weeks</time_frame>
    <description>Change in Body Fat</description>
  </other_outcome>
  <other_outcome>
    <measure>Body composition - Body Fat free mass</measure>
    <time_frame>12 weeks</time_frame>
    <description>change in Body Fat free mass</description>
  </other_outcome>
  <other_outcome>
    <measure>Body composition - Visceral Fat mass</measure>
    <time_frame>12 weeks</time_frame>
    <description>change in Visceral Fat mass</description>
  </other_outcome>
  <other_outcome>
    <measure>Body Circumferences - arm</measure>
    <time_frame>12 weeks</time_frame>
    <description>change in circumferences (arm)</description>
  </other_outcome>
  <other_outcome>
    <measure>Body Circumferences - calf</measure>
    <time_frame>12 weeks</time_frame>
    <description>change in circumferences (calf)</description>
  </other_outcome>
  <other_outcome>
    <measure>Body Circumferences - waist</measure>
    <time_frame>12 weeks</time_frame>
    <description>change in circumferences ( waist)</description>
  </other_outcome>
  <other_outcome>
    <measure>Body Circumferences - hips</measure>
    <time_frame>12 weeks</time_frame>
    <description>change in circumferences (hips)</description>
  </other_outcome>
  <other_outcome>
    <measure>Iron</measure>
    <time_frame>12 weeks</time_frame>
    <description>Change in blood Iron concentration</description>
  </other_outcome>
  <other_outcome>
    <measure>Other biochemical parameters - vit D</measure>
    <time_frame>12 weeks</time_frame>
    <description>Change in blood vitamin D</description>
  </other_outcome>
  <other_outcome>
    <measure>Other biochemical parameters - vit B12</measure>
    <time_frame>12 weeks</time_frame>
    <description>Change in blood vitamin B12</description>
  </other_outcome>
  <other_outcome>
    <measure>Other biochemical parameters - Folates</measure>
    <time_frame>12 weeks</time_frame>
    <description>Change in blood Folates</description>
  </other_outcome>
  <other_outcome>
    <measure>Other biochemical parameters - transferrin</measure>
    <time_frame>12 weeks</time_frame>
    <description>Change in transferrin</description>
  </other_outcome>
  <other_outcome>
    <measure>Other biochemical parameters - Homocystein</measure>
    <time_frame>12 weeks</time_frame>
    <description>Change in Homocystein</description>
  </other_outcome>
  <other_outcome>
    <measure>Other biochemical parameters - albumin</measure>
    <time_frame>12 weeks</time_frame>
    <description>Change in blood proteins (albumin)</description>
  </other_outcome>
  <other_outcome>
    <measure>Other biochemical parameters - prealbumin</measure>
    <time_frame>12 weeks</time_frame>
    <description>Change in blood proteins (prealbumin)</description>
  </other_outcome>
  <other_outcome>
    <measure>Other biochemical parameters - enzymes - lipase</measure>
    <time_frame>12 weeks</time_frame>
    <description>Change in blood enzymes (lipase)</description>
  </other_outcome>
  <other_outcome>
    <measure>Other biochemical parameters - enzymes - amylase</measure>
    <time_frame>12 weeks</time_frame>
    <description>Change in blood enzymes (amylase)</description>
  </other_outcome>
  <other_outcome>
    <measure>Other biochemical parameters - thyroid hormones - FT3</measure>
    <time_frame>12 weeks</time_frame>
    <description>Change in FT3</description>
  </other_outcome>
  <other_outcome>
    <measure>Other biochemical parameters - thyroid hormones - FT4</measure>
    <time_frame>12 weeks</time_frame>
    <description>Change in FT4</description>
  </other_outcome>
  <other_outcome>
    <measure>Other biochemical parameters - thyroid hormones - TSH</measure>
    <time_frame>12 weeks</time_frame>
    <description>Change in TSH</description>
  </other_outcome>
  <other_outcome>
    <measure>Other biochemical parameters - inflammatory markers - CRP</measure>
    <time_frame>12 weeks</time_frame>
    <description>Change in C-reactive protein</description>
  </other_outcome>
  <other_outcome>
    <measure>Other biochemical parameters - inflammatory markers - ESR</measure>
    <time_frame>12 weeks</time_frame>
    <description>Change in Erythrocyte Sedimentation Rate</description>
  </other_outcome>
  <other_outcome>
    <measure>Other biochemical parameters - creatinin</measure>
    <time_frame>12 weeks</time_frame>
    <description>Change in blood creatinin</description>
  </other_outcome>
  <other_outcome>
    <measure>Uric acid</measure>
    <time_frame>12 weeks</time_frame>
    <description>Change in uric acid blood concentration</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">151</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>All participants</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Obese subjects with BMI &gt;= 30 and with one or more of metabolic comorbidities (type 2 diabetes mellitus, dyslipidemia, high blood pressure, hyperuricemia, and others).</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Multidisciplinary treatment of obesity (diet + vitamin D + exercise + psychotherapy)</intervention_name>
    <description>Body weight reduction was induced by a low-energy mixed diet (55 % carbohydrates, 30 % lipids and 15 % proteins) providing 600 kcal less than individually estimated energy requirements based on the measured REE. The energy content and macronutrient composition of the diets adhered to the nutritional recommendations of the American Diabetes Association.&#xD;
Patients were administered vitamin D supplement only if they presented a value of 25-hydroxyvitamin D (25OHD) &lt;30 ng/ml in blood tests at the beginning.&#xD;
Patients were following an individualized physical activity plan within the hospital and were aided by a psychodynamic approach therapist.</description>
    <arm_group_label>All participants</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age &gt;= 18&#xD;
&#xD;
          -  BMI &gt;= 30&#xD;
&#xD;
          -  one or more comorbidities (type 2 diabetes mellitus, dyslipidemia, high blood&#xD;
             pressure, hyperuricemia, and others)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  active cancer&#xD;
&#xD;
          -  severe cognitive or functional impairments&#xD;
&#xD;
          -  severe behavioral disorders&#xD;
&#xD;
          -  known kidney failure (previous glomerular filtration rate &lt;30 ml/min)&#xD;
&#xD;
          -  known liver failure (Child B or C)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mariangela Rondanelli, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Azienda di Servizi alla Persona di Pavia</affiliation>
  </overall_official>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>October 31, 2020</study_first_submitted>
  <study_first_submitted_qc>November 5, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 10, 2020</study_first_posted>
  <last_update_submitted>November 5, 2020</last_update_submitted>
  <last_update_submitted_qc>November 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Weight Loss</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>IPD are not shared. Published article will display mean baseline values and mean differences from baseline.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

